Home » Courtagen Inks Emerging Markets Deal with Alliance Global Group

Courtagen Inks Emerging Markets Deal with Alliance Global Group

Nov 15, 2012
|
a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Courtagen Life Sciences today said that Alliance Global Group will distribute the firm's molecular diagnostic tests in certain emerging markets.

Dubai-based Alliance Global sells biomedical products in the Middle East, Africa, and Asia. It will have exclusive rights to distribute a number of Courtagen tests for genetically based disorders. Thus far, the Woburn, Mass.-based firm offers tests for mitochondrial disorders and a new panel for epilepsy and seizure. Courtagen also plans to develop tests for other neurological disorders.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Articles

May 29, 2014

Courtagen Inks NGS Test Distribution Agreement with Sciencewerke

Jun 25, 2014

Bioinn to Distribute Courtagen's NGS Tests in Taiwan

Apr 23, 2014

Courtagen and Connecticut Children's Medical Center Partner to ID Autism Genes

Mar 25, 2014

Courtagen to Provide Genetic Profiling for Raptor's Mitochondrial Disorder Drug Trial

May 15, 2014

Q&A: Courtagen's Kevin McKernan on Skirting Sequencing Gene Patents With Novel PCR Methods

Premium
Jun 20, 2014

Courtagen Raises $6.3M

The Scan

This Week in Science

In Science this week: gene linked to expansion of the human neocortex, and more.

Bit of an Increase

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.

Ancient Wheat

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

'High School Never Ends'

Joel Achenbach explores at National Geographic why people find science difficult to believe.

What's Popular?

In Clinical Sequencing

  1. AGBT: WashU Applies Genomic Testing to Predict Cancer Relapse, Drug Response, Vaccine Epitopes

    Premium

  2. Population Study Prompts New View of Monarch Butterfly Migratory History

  3. AGBT: Life Tech Updates on PII Chip; Customers Present Early Data from Ion Chef, Hi-Q Chemistry

    Premium

  4. Natera Study Shows High PPV for NIPT; Company Looks Toward Low-risk Market, Cancer Testing

    Premium

  5. On Heels of Sequenom Deal, Quest to Stop Offering Natera NIPT

Sponsorships

Privacy Policy.  Copyright © 2015 Genomeweb LLC.  All Rights Reserved.